QIAGEN

YTD

ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell QIAGEN and other ETFs, options, and stocks.

About QGEN

QIAGEN NV is a holding company, which engages in the provision of Sample to Insight solutions that enable customers to gain valuable molecular insights from samples containing the building blocks of life. Its sample technologies isolate and process DNA, RNA, and proteins from blood, tissue, and other materials.

CEO

Thierry L. Bernard

CEOThierry L. Bernard

Employees

5,765

Employees5,765

Headquarters

Venlo, Limburg

HeadquartersVenlo, Limburg

Founded

1996

Founded1996

Employees

5,765

Employees5,765

QGEN Key Statistics

Market cap

8.31B

Market cap8.31B

Price-Earnings ratio

19.89

Price-Earnings ratio19.89

Dividend yield

0.65%

Dividend yield0.65%

Average volume

2.43M

Average volume2.43M

High today

$40.43

High today$40.43

Low today

$39.80

Low today$39.80

Open price

$40.29

Open price$40.29

Volume

882.73K

Volume882.73K

52 Week high

$57.82

52 Week high$57.82

52 Week low

$38.13

52 Week low$38.13

Stock Snapshot

As of today, QIAGEN(QGEN) shares are valued at $40.19. The company's market cap stands at 8.31B, with a P/E ratio of 19.89 and a dividend yield of 64.7%.

On 2026-03-20, QIAGEN(QGEN) stock moved within a range of $39.80 to $40.43. With shares now at $40.19, the stock is trading +1.0% above its intraday low and -0.6% below the session's peak.

Trading volume for QIAGEN(QGEN) stock has reached 882.73K, versus its average volume of 2.43M.

Over the past 52 weeks, QIAGEN(QGEN) stock has traded between a high of $57.82 and a low of $38.13.

QGEN News

Simply Wall St 17h

Qiagen’s TB And GI Testing Moves Draw Investor Valuation Interest

Qiagen (NYSE:QGEN) reported new clinical data supporting its QuantiFERON-TB Gold Plus test for tuberculosis infection, with a focus on immunocompromised and oth...

TipRanks 21h

Qiagen announces newly published data supporting efficacy of QuantiFERON

QIAGEN (QGEN) N.V. “announced newly published clinical and health economic data supporting the use of its QuantiFERON-TB Gold Plus blood test for detecting tube...

TipRanks 7d

BlackRock Discloses 10.29% Capital Interest and 11.43% Voting Stake in Qiagen

Qiagen ( (QGEN) ) has shared an announcement. Qiagen has disclosed a notification from the Dutch financial regulator AFM showing that BlackRock, Inc. and vario...

Analyst ratings

63%

of 24 ratings

Buy

37.5%

Hold

62.5%

Sell

People also own

Based on the portfolios of people who own QGEN. This list is generated using Robinhood data, and it’s not a recommendation.

Similar Marketcap

This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.

Popular Stocks

This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset

Newly Listed

This list is generated by showing companies that recently went public.